In order to address a role for p53 in the sensitivity to IKK inhibition, we analyzed cells isolated from KRAS-induced lung cancer mouse models with WT p53 (KE67) and with deletion of the p53 gene (KPF54). Here, KRAS is linked to lung carcinoma.